MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.13112

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measures.

Reas Emilie T, Shadrin Alexey, Frei Oleksandr, Motazedi Ehsan, McEvoy Linda, Bahrami Shahram, van der Meer Dennis, Makowski Carolina, Loughnan Robert, Wang Xin, Broce Iris, Banks Sarah J, Fominykh Vera, Cheng Weiqiu, Holland Dominic, Smeland Olav B, Seibert Tyler, Selbaek Geir, Brewer James B, Fan Chun C, Andreassen Ole A, Dale Anders M, Alzheimer's Disease Neuroimaging Initiative

СтатьяПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

INTRODUCTION

There is a pressing need for non-invasive, cost-effective tools for early detection of Alzheimer's disease (AD).

METHODS

Using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), Cox proportional models were conducted to develop a multimodal hazard score (MHS) combining age, a polygenic hazard score (PHS), brain atrophy, and memory to predict conversion from mild cognitive impairment (MCI) to dementia. Power calculations estimated required clinical trial sample sizes after hypothetical enrichment using the MHS. Cox regression determined predicted age of onset for AD pathology from the PHS.

RESULTS

The MHS predicted conversion from MCI to dementia (hazard ratio for 80th versus 20th percentile: 27.03). Models suggest that application of the MHS could reduce clinical trial sample sizes by 67%. The PHS alone predicted age of onset of amyloid and tau.

DISCUSSION: The MHS may improve early detection of AD for use in memory clinics or for clinical trial enrichment.

HIGHLIGHTS: A multimodal hazard score (MHS) combined age, genetics, brain atrophy, and memory. The MHS predicted time to conversion from mild cognitive impairment to dementia. MHS reduced hypothetical Alzheimer's disease (AD) clinical trial sample sizes by 67%. A polygenic hazard score predicted age of onset of AD neuropathology.

Для цитирования: Reas Emilie T, Shadrin Alexey, Frei Oleksandr, Motazedi Ehsan, McEvoy Linda, Bahrami Shahram, van der Meer Dennis, Makowski Carolina, Loughnan Robert, Wang Xin, Broce Iris, Banks Sarah J, Fominykh Vera, Cheng Weiqiu, Holland Dominic, Smeland Olav B, Seibert Tyler, Selbaek Geir, Brewer James B, Fan Chun C, Andreassen Ole A, Dale Anders M, Alzheimer's Disease Neuroimaging Initiative. Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measures.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023. DOI: 10.1002/alz.13112.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.